Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/10/22
End: 10/31/30
Due: 10/31/31
Phase: N/A
Priority: Normal
Start: 02/15/25
End: 01/31/32
Due: 01/31/33
Phase: N/A
Priority: Normal
Start: 11/01/24
End: 05/01/27
Due: 05/01/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| GNT0006 Gene Therapy Trial in Patients With LGMDR9 | NCT05224505 | Atamyo Therapeutics | user2@example.com | None | 2022-08-10 | 2030-10-31 | 2031-10-31 | - | - | 2025-07-14 |
| ATA-200 Dose-escalation Gene Therapy Trial in Patients with LGMDR5 | NCT05973630 | Atamyo Therapeutics | user2@example.com | None | 2025-02-15 | 2032-01-31 | 2033-01-31 | - | - | 2025-07-14 |
| Natural History Study in Patients With LGMDR5/2c | NCT06210672 | Atamyo Therapeutics | user2@example.com | None | 2024-11-01 | 2027-05-01 | 2028-05-01 | - | - | 2025-07-14 |